Blog
Why the "Network Effect" is Crucial for TripAdvisor
TripAdvisor (NASDAQ: TRIP) is the largest online travel review site and may be of interest to contrarian investors. The stock is down almost 45% in the past 12 months, yet the company sports one of
5 Highly Respected Investors Who Are Worried About the Market Right Now
If you think the stock market is high right now, you're in good company. Some of the world's most revered investors are saying the very same thing.Investors should consider the wisdom of people like
Why Tenet Healthcare Shares Dropped 14.4% Today
After reporting second-quarter earnings and offering up guidance for 2017, shares of Tenet Healthcare (NYSE: THC) have fallen 14.6% as of 2:30 p.m. EDT on Tuesday.Tenet Healthcare's year-over-year
Why J.C. Penney Company, Inc. Stock Jumped 16% Last Month
Shares of J.C. Penney Company, Inc. (NYSE: JCP) bounced back last month. The stock rose both on better news in the retail industry, and because it was perceived as a value play after falling sharply
The Key Reason Alexion Pharmaceuticals, Inc. Vaulted 13% Higher in July
Shares of Alexion Pharmaceuticals (NASDAQ: ALXN), a biotech company with a keen focus on developing therapies to treat ultra-rare diseases, moved steadily higher by 13% during the month of July
What Happened in the Stock Market Today
Stocks pulled back modestly today, with the Dow Jones Industrial Average (DJINDICES: ^DJI) dropping for the first time in 10 sessions while the S&P 500 (SNPINDEX: ^GSPC) incurred a similarly small
Why Avis Budget Group, Depomed, and Tenet Healthcare Slumped Today
Investors saw the end of a historic bullish streak for stocks on Tuesday, as the Dow Jones Industrials failed in their bid for a 10th straight day of record-setting gains. Instead, major benchmarks
Why Ralph Lauren, LendingClub, and FibroGen Jumped Today
Tuesday was a letdown for investors, with stocks spending much of the day in positive territory but then giving up ground toward the end of the trading session. Major benchmarks fell roughly 0.15% to
Why MercadoLibre's Second-Quarter Profit Problem Is Probably Just a Hiccup
In this segment from Motley Fool Money, host Chris Hill, Total Income's Ron Gross, and Supernova and Rule Breakers' David Kretzmann look beyond the headline numbers as they consider the investment
Argus Upgrades Tesla, Sets $444 Price Target
Shares of Tesla (NASDAQ: TSLA) jumped today thanks to an analyst upgrade. Argus Research analyst Bill Selesky has now boosted his rating on shares of the electric-car maker from hold to buy, while
MyoKardia Inc. Is on the Rise Again Today -- Here's Why
After a monster run-up on Monday, MyoKardia Inc. (NASDAQ: MYOK) climbed another 145.9% as of 3:30 p.m. during Tuesday's session. It seems investors still giddy about positive clinical trial data
Tesla, Inc.'s Model 3 Battery Sizes -- What Investors Need to Know
Since electric-car maker Tesla (NASDAQ: TSLA) fully unveiled its Model 3 and delivered the first units to customers last month, there's been speculation about what battery size the vehicle sports. In
3 Dividend Stocks for Retirement
Investing in retirement can be very different than investing early in life. Priorities may transition from growth to cash flow, and investors may want to avoid some high-risk industries altogether
Why Teva Pharmaceutical and Under Armour Are Looking So Unhealthy
In this segment from Motley Fool Money, host Chris Hill, Million Dollar Portfolio's Jason Moser, Total Income's Ron Gross, and Supernova and Rule Breakers' David Kretzmann first consider the
Standard & Poors Takes a (Small) Stand for Shareholders' Rights
In this segment from Motley Fool Money, host Chris Hill, Million Dollar Portfolio's Jason Moser, Total Income's Ron Gross, and Supernova and Rule Breakers' David Kretzmann discuss what led the S&P to
Textainer Group Holdings Limited's Results Improve and Outlook Is Brightening
The container shipping market is slowly coming out of its cyclical downturn, which is starting to drive a noticeable improvement in Textainer Group Holdings Limited's (NYSE: TGH) financial results
The High Points From Hanesbrands Inc.'s Q2 2017 Report
Hanesbrands Inc. (NYSE: HBI), the maker of underwear and other clothing essentials, turned in a solid report card for the second quarter last week and said it remains on track to deliver on 2017
3 Stocks Retirees Should Consider
Retirement saving doesn't end when you retire. People are living longer than ever, so it's important to stretch that nest egg to cover those extra years. High-quality stocks can help you do exactly
Earnings Beat Sends Shares of Ritchie Bros. Auctioneers Nearly 9% Higher
Shares of Ritchie Bros. Auctioneers (NYSE: RBA), a global auction company offering solutions for buying and selling used heavy equipment, trucks, and other massive industrial assets, are rising 9%
Here's Why RigNet Stock Is Slumping Today
Shares of RigNet (NASDAQ: RNET) sold off on Tuesday, down more than 11% as of 2:45 p.m. EDT, after the remote communications specialist reported second-quarter results.RigNet posted mixed results this
Here's Why Shares of Spirit Airlines Plummeted 25% in July
According to S&P Global Market Intelligence, shares of Spirit Airlines (NASDAQ: SAVE) dropped about 25% last month. The was the result, in part, of what investors interpreted as a lackluster
3 Keys to Apple's $45 Billion in Q3 Revenue
In this segment from Motley Fool Money, host Chris Hill, Million Dollar Portfolio's Jason Moser, Total Income's Ron Gross, and Supernova and Rule Breakers' David Kretzmann break down the impressive
Why J. C. Penney Company, Inc. Shareholders Have Nothing to Worry About
While J.C. Penney (NYSE: JCP) often gets lumped in with other struggling retailers, the chain has made major progress on its turnaround efforts.That does not mean it's not struggling. The chain saw a
Sempra Energy's Cameron LNG Delay Isn't Getting in the Way of Earnings
If I were to tell you that Sempra Energy (NYSE: SRE) announced it expects its Cameron LNG facility to be delayed by up to a year, I guess you would think that the company's stock would drop. The
Synergy Pharmaceuticals Inc. Tanked 14.2% in July -- but Why?
Synergy Pharmaceuticals (NASDAQ: SGYP), a commercial-stage biopharma focused on gastrointestinal diseases, fell more than 14% in July, according to data from S&P Global Market Intelligence. However